FDA Issues Complete Response Letter To Centocor for Ustekinumab …
Friday, December 19th, 2008 at
7:26 am
Leave your comment
Centocor has already brought innovation to the treatment of Crohn’s disease, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis , ulcerative colitis, pediatric Crohn’s disease and psoriasis. …
